TITLE

Validation of FEV6 in the elderly: correlates of performance and repeatability

AUTHOR(S)
Bellia, V.; Sorino, C.; Catalano, F.; Augugliaro, G.; Scichilone, N.; Pistelli, R.; Pedone, C.; Antonelli-Incaizi, A.
PUB. DATE
January 2008
SOURCE
Thorax;Jan2008, Vol. 63 Issue 1, p60
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Forced expiratory volume in 6 s (FEV6) has been proposed as a more easily measurable parameter than forced vital capacity (FVC) to diagnose airway disease using spirometry. A study was undertaken to estimate FEV6 repeatability, to identify correlates of a good quality FEV6 measurement and of volumetric differences between FEV6 and FVC in elderly patients. Methods: 1531 subjects aged 65-100 years enrolled in the SA.R.A project (a cross-sectional multicentre non-interventional study) were examined. FEV6 was measured on volume-time curves that achieved satisfactory start-of-test and end-of-test criteria. Correlates of FEV6 achievement were assessed by logistic regression. Results: Valid FEV6 and FVC measurements were obtained in 82.9% and 56.9%, respectively, of spirometric tests with an acceptable start-of-test criterion. Female sex, older age, lower educational level, depression, cognitive impairment and lung restriction independently affected the achievement of FEV6 measurement. Good repeatability (difference between the best two values <150 ml) was found in 91.9% of tests for FEV6 and in 86% for FVC; the corresponding figures in patients with airway obstruction were 94% and 78.4%. Both FEV6 and FVC repeatability were affected by male sex and lower education. Male sex, airway obstruction and smoking habit were independently associated with greater volumetric differences between FEV6 and FVC. Conclusions: In elderly patients, FEV6 measurements are more easily achievable and more reproducible than FVC although 1/6 patients in this population were unable to achieve them.
ACCESSION #
28681903

 

Related Articles

  • Therapy for Chronic Obstructive Pulmonary Disease in the 21st Century. Donnelly, Louise E.; Rogers, Duncan F. // Drugs;2003, Vol. 63 Issue 19, p1973 

    Chronic obstructive pulmonary disease (COPD) is a common, smoking-related, severe respiratory condition characterized by progressive, irreversible airflow limitation. Current treatment of COPD is symptomatic, with no drugs capable of halting the relentless progression of airflow obstruction....

  • Airway Surface Dehydration Aggravates Cigarette Smoke-Induced Hallmarks of COPD in Mice. Seys, Leen J. M.; Verhamme, Fien M.; Dupont, Lisa L.; Desauter, Elke; Duerr, Julia; Seyhan Agircan, Ayca; Conickx, Griet; Joos, Guy F.; Brusselle, Guy G.; Mall, Marcus A.; Bracke, Ken R. // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Introduction: Airway surface dehydration, caused by an imbalance between secretion and absorption of ions and fluid across the epithelium and/or increased epithelial mucin secretion, impairs mucociliary clearance. Recent evidence suggests that this mechanism may be implicated in chronic...

  • Diagnosis and Management of Stable COPD. Achilleos, Katerina M.; Powrie, Duncan J. // British Journal of Medical Practitioners;2011, Vol. 4 Issue 3, p23 

    The article reports on the chronic obstructive and pulmonary disease (COPD) which is caused by smoking and to less extent by environmental and occupational factors. Suggested diagnosis of COPD includes spirometry, pulmonary function tests and chest radiograph. Further information is given about...

  • Smoking History and Bronchitis Symptoms Should Prompt a Spirometry Test for COPD. Marshall, Adriene // Pulmonary Reviews;Dec2008, Vol. 13 Issue 12, p1 

    The article focuses on a study which found that more than 25% of primary care patients with symptoms of chronic bronchitis and a long-standing history of smoking had undiagnosed chronic obstructive pulmonary disease (COPD). It was also found that 47% of study participants reported having slight...

  • The probable risk factors for developing COPD in women. Kuzubova, N. A.; Kiseleva, E. A.; Titova, O. N.; Kovaleva, L. F. // Vestnik Sankt-Peterburgskogo universiteta, Seriia 7: Geologia, G;2013, Issue 2, p234 

    The article presents an analysis of possible risk factors for chronic obstructive pulmonary disease (COPD) based on questionnaires and spirometric data of 304 women (mean age - 51,6±3,8 years). Respiratory symptoms, history of smoking, work in dust pollution conditions, respiratory diseases...

  • The Role of MAPK and Nrf2 Pathways in Ketanserin-Elicited Attenuation of Cigarette Smoke–Induced IL-8 Production in Human Bronchial Epithelial Cells. Lau, Way Kwok Wai; Chan, Stanley Chi Hang; Law, Andrew Chi Kin; Ip, Mary Sau Man; Mak, Judith Choi Wo // Toxicological Sciences;Feb2012, Vol. 125 Issue 2, p569 

    Cigarette smoking is a major risk factor in chronic obstructive pulmonary disease (COPD) with chronic airway inflammation as a key feature. Blockade of serotonin receptor 2A (5-HTR2A) with ketanserin has been found to improve lung function in COPD patients. Furthermore, ketanserin has been shown...

  • P2X7 Receptor and Caspase 1 Activation Are Central to Airway Inflammation Observed after Exposure to Tobacco Smoke. Eltom, Suffwan; Stevenson, Christopher S.; Rastrick, Joseph; Dale, Nicole; Raemdonck, Kristof; Wong, Sissie; Catley, Matthew C.; Belvisi, Maria G.; Birrell, Mark A. // PLoS ONE;2011, Vol. 6 Issue 9, p1 

    Chronic Obstructive Pulmonary Disease (COPD) is a cigarette smoke (CS)-driven inflammatory airway disease with an increasing global prevalence. Currently there is no effective medication to stop the relentless progression of this disease. It has recently been shown that an activator of the...

  • Smoking in patients with advanced lung disease. Tattersfield, Anne E. // British Medical Journal (Clinical Research Edition);1/15/1983, Vol. 286 Issue 6360, p163 

    Examines the effect of smoking on people with lung disease in Great Britain. Factors contributing on the development of chronic bronchitis and emphysema; Symptoms of the disease; Benefit of stopping from smoking.

  • FEV6 as screening tool in spirometric diagnosis of obstructive airway disease. Malolan, P. Adithya; Acharya, Vishak; Unnikrishnan, B. // Lung India;Apr-Jun2010, Vol. 27 Issue 2, p63 

    Context: The use of spirometry is currently limited to the diagnosis of obstructive airway disease for tertiary centers mainly because of the unmet need for technical expertise and funding. Use in primary care asks for a simpler and cost-effective screening tool for obstructive airway disease....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics